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Though the vascular endothelial growth factor coreceptor neuropilin-1 (Nrp1) plays a critical role in
vascular development, its precise function is not fully understood. We identiﬁed a group of novel
binding partners of the cytoplasmic domain ofNrp1 that includes the focal adhesion regulator, Filam-
inA (FlnA). Endothelial cells (ECs) expressingaNrp1mutantdevoidof the cytoplasmicdomain (nrp1cyto-
D/D) migrated signiﬁcantly slower in response to VEGF relative to the cells expressing wild-type Nrp1
(nrp1+/+ cells). The rate of FA turnover inVEGF-treatednrp1cytoD/DECswas anorder ofmagnitude lower
in comparison to nrp1+/+ ECs, thus accounting for the slower migration rate of the nrp1cytoD/D ECs.
Structured summary of protein interactions:
NRP1 physically interacts with alpha enolase,Myh10,Myh9, EEF1alpha1 and FlnA by anti bait coimmu-
noprecipitation (View interaction)
FlnA and NRP1 colocalize by ﬂuorescence microscopy (View interaction)
NRP1 and rab11 colocalize by ﬂuorescence microscopy (View interaction)
NRP1 physically interacts withMyh10, Dync1h1, Myh9 and EEF1alpha1 by anti bait coimmunoprecipi-
tation (View interaction)
NRP1 and FlnA bind by isothermal titration calorimetry (View interaction)
NRP1 physically interacts with p130Cas by anti bait coimmunoprecipitation (View interaction)
NRP1 and p130Cas colocalize by ﬂuorescence microscopy (View interaction)
NRP1 binds to FlnA by surface plasmon resonance (View interaction)
 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Nrp is a single-pass transmembrane protein, which has a highly
conserved short cytoplasmic domain that lacks catalytic activity
[1,2]. While the downstream signaling of the tyrosine kinase recep-
tor of vascular endothelial growth factor (VEGF)-A, VEGF receptor 2
(VEGFR2), has been the subject of numerous studies and its major
elements have been established [3], the contribution of Nrp1 to
VEGF signaling is less well understood. Several studies suggested
that Nrp1 might have a VEGFR2-independent function in mediat-
ing VEGF signaling [4–7]. Indeed, Nrp1 has binding partners otherthan VEGFR2, such as receptors of the plexin family [8], but it re-
mains unclear how the cytoplasmic domain of Nrp1 mediates sig-
naling. Presumably, the cytoplasmic domain could recruit other
proteins that may be able to transduce VEGF signaling. The best
studied Nrp1 cytoplasmic binding protein is synectin, also named
Nrp1-interacting protein (NIP) [9]. Synectin contains a single PDZ
(postsynaptic density 95, disk large, zona occludens-1) domain,
through which it binds to the C-terminus of Nrp1. Synectin recruits
the molecular motor myosin VI to uncoated endocytic vesicles,
thus facilitating the trafﬁcking of endocytosed membrane recep-
tors [10], such as VEGFR2 in complex with Nrp1, to promote arte-
riogenesis [11].
Focal adhesions are large aggregates of proteins that anchor the
cell to the extracellular matrix and that undergo cycles of assembly
and disassembly during cell movement [12,13]. Among other sig-
nals, the dynamics of FAs are regulated by growth factors [14],
Table 1
Protein ligands of the Nrp1 cytoplasmic domain that were identiﬁed by LC–MS. The
protein name, gene name, peptide coverage, and Mascot scores are listed.
Protein Band
number
Gene
name
Peptides Mascot
score
Non-muscle myosin IIa heavy
chain
2, 5, 6 myh9 83 5871
Non-muscle myosin IIb heavy
chain
2, 5, 6 myh10 40 2479
Cytoplasmic dynein heavy
chain 1
1 dyhc1 4 148
Filamin A 4 ﬂnA 2 85
Eukaryotic translation
elongation factor 1 a1
3, 7 ef1a1 5 275
a enolase 8 enoa 3 175
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angiogenesis during development and in the adult organism
[16,17]. Treatment with VEGF increased FA density in ECs [18].
The signaling of VEGF to FAs appeared to follow the canonical VEG-
FR2-dependent pathway, and to be mediated by the non-receptor
FA kinase (FAK), and by a closely related kinase, Pyk2 [19] The
VEGF-induced increase in FA assembly was accompanied by an in-
crease in EC migration. Though Nrp1 had not been observed di-
rectly in FAs [19], proteomics studies identiﬁed the VEGF co-
receptor Nrp1 as a FA component [20].
The regulation of FA turnover is not fully understood, and it is
likely to involve multiple molecular mechanisms [13]. One of
these invoked FlnA [18], a large scaffold protein that binds ﬁla-
mentous actin (F-actin) and numerous other proteins, including
transmembrane receptors [21,22]. FlnA is composed of 24 IgG re-
peats including a C-terminal dimerization domain [21]. Most of
its ligands, excluding F-actin, bind to the last three C-terminal
IgG repeats.
Here, we investigated if the Nrp1-mediated intracellular signal-
ing of VEGF originates from a protein complex bound to the cyto-
plasmic domain of Nrp1. We ﬁrst combined immunoprecipitation
and mass spectroscopy to identify several novel Nrp1-associated
proteins, including FlnA. Separately, we found by immunoprecipi-
tation and immunoblotting that the scaffold protein p130Cas also
associates with Nrp1. Both proteins are known to be involved in
the dynamics of FAs [23]. We tested, therefore, if Nrp1 is involved
in FA turnover. Our results support this premise.
2. Materials and methods
See Supplemental materials.
3. Results
3.1. Identiﬁcation of novel ligands to the cytoplasmic domain of Nrp1
We used a proteomics approach to identify cytoplasmic pro-
teins that associate with Nrp1. Immunoprecipitates of Nrp1 fromFig. 1. Identiﬁcation of novel binding partners for the cytoplasmic domain of Nrp1.
Coomassie-stained tris-glycine acrylamide (10%) showing bands of proteins
immunoprecipitated by Nrp1 from primary mouse heart ECs incubated without
or with 20 ng/ml VEGF-A165 for 10 min. (1) Dynein heavy chain; (2) myosin heavy
chains 9 and 10; (3) eukaryotic translation elongation factor 1 a1; (4) ﬁlamin A; (5
and 6) myosin heavy chains 9 and 10; (7) eukaryotic translation elongation factor 1
a1; (8) a enolase. None of these bands were present in a sample that was
immunoprecipitated by non-immune goat IgG (not shown). Table 1 listing the
proteins that were coimmunoprecipitated together with Nrp1, and whose corre-
sponding bands were identiﬁed by LC–MS.quiescent and from VEGF-A164-treated (20 ng/ml, 5 min) primary
mouse heart ECs were resolved by SDS–PAGE. The band patterns
of the two samples were partially different (Fig. 1ote, Table 1).
The proteins were identiﬁed by liquid chromatography–tandem
mass spectroscopy (LC–MS). In the quiescent ECs, these proteins
were cytoplasmic dynein heavy chain 1 (Dync1h1), myosin heavy
chains 9 and 10 (Mhy9, Mhy10), and eukaryotic translation elonga-
tion factor 1 a1 (EEF1a1). Mhy9, Mhy10, and EEF1a1 were present
in the immunoprecipitate from both VEGF-treated and quiescent
ECs. Mhy9 and Myh10 are subunits of non-muscle myosin II,
known also as heavy chains IIa and IIb. They are involved in endo-
somal trafﬁcking [24], cytokinesis [25], and cell shape remodeling
[26], and are localized to early endosomes, stress-ﬁbers, and FAs
[27]. The proteins unique to the VEGF-treated sample were a-eno-
lase and Filamin-A (FlnA). Due to its connection to the actin cyto-
skeleton and protein transport, the involvement of FlnA was
investigated further.
3.2. FlnA binds Nrp1 directly
Given that FlnA binds directly several classes of transmembrane
receptors [21,22], we sought to determine if the association of FlnA
to Nrp1 is similarly direct. As shown by the MS analysis, we iden-
tiﬁed Nrp1 as an FlnA-associated protein by co-immunoprecipita-
tion from the lysate of nrp1+/+ ECs (Fig. 1). We used two
independent in vitro approaches to test if FlnA and Nrp1 are capa-
ble to bind directly to each other. First, we used surface plasmon
resonance (SPR) to determine the equilibrium binding kinetics be-
tween FlnA and the Nrp1 cytoplasmic domain. FlnA is a modular
protein consisting of 24 immunoglobulin-like (Ig) repeats, which
bind several proteins including F-actin. We tested the interaction
of Nrp1 cytoplasmic region with the most common binding sites
of FlnA, the repeats 10–11, 18, 19, 20, 21, 22 and 23–24 of FlnA
and found that only repeats 23–24 of FlnA associates with the
Nrp1 cytoplasmic region with an appreciable afﬁnity (KD of
9.6 ± 1.2 lM) (Fig. 2A–C). This was conﬁrmed by isothermal titra-
tion calorimetry, which showed a closely similar dissociation con-
stant of 12.1 ± 2.0 lM (Fig. 2D).
3.3. Nrp1 colocalizes with FlnA in vesicles in response to VEGF-A
To gain insight into the functional signiﬁcance of the interaction
between Nrp1 and FlnA, we tracked their localization in VEGF-A-
treated nrp1+/+ ECs. Whereas there was little or no colocalization
in quiescent ECs (Fig. 3A), the two proteins colocalized extensively
in vesicular punctae in the cytoplasm 5 min after the introduction
of VEGF-A (Fig. 3B). The extent of colocalization decreased at the
later time points of 10 and 30 min (Fig. 3C–E).
To test for the dependence of the colocalization of Nrp1 and
FlnA on the cytoplasmic interaction of the two proteins, we probed
Fig. 2. Binding between FlnA and the Nrp1 cytoplasmic domain. (A) SPR sensorgrams of FlnA repeats 23-24 binding to immobilized Nrp1 cytoplasmic region. A range of
analyte concentrations were tested, which showed concentration dependence of binding. (B) The ﬁtted SPR binding data gives a dissociation constant, KD, of 9.6 (±1.2) lM. (C)
SPR data for the interaction between Nrp1 cytoplasmic region and FlnA repeats 10–11; there was no observable binding between the two domains. (D) ITC binding data for
the titration of Nrp1 cytoplasmic domain (0.4 mM) with FlnA repeats 23–24 (0.04 mM). The Nrp1 cytoplasmic region bound these repeats with a KD of 12.9 (±2.0) lM.
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undergo noticeable redistribution after the application of VEGF-A,
and it did not colocalize with FlnA (Fig. 3A0 and B0). Rather, Nrp1
remained concentrated along the cell edges, as in quiescent
nrp1cytoD/D cells.
3.4. Nrp1 associates with FA proteins
Because of the known association of FlnA with FAs, we sought,
to determine if Nrp1 binds other FA proteins. Several studies had
shown that Nrp1-dependent cell migration is mediated by
p130Cas and its tyrosine phosphorylation [19,28,29]. We sought,
therefore, to test if the two proteins associate with each other
in a VEGF-dependent manner. Nrp1 and p130Cas colocalized
extensively in quiescent ECs (Fig. 4A–D), and remained colocal-
ized to a similar degree 30 min after the administration of VEGF
(Fig. 4E). This is vastly different from the colocalization of Nrp1
with FlnA, which was much more transient. Further, Nrp1 and
p130Cas coimmunoprecipitated in both quiescent EC and VEGF-treated ECs, similar to their colocalization (Fig. 4F). Despite the
observed presence of p130Cas in FAs [30], we detected p130Cas
only in vesicular punctae. Apparently, the p130Cas that we visu-
alized was a dynamic fraction that may have been recycling to
and/or from FAs, whereas the association with FAs may have been
too transient to be detected at the time points we sampled. Sim-
ilar to FlnA, Nrp1 and p130Cas did not colocalize in nrp1cytoD/D
ECs (Fig. 4A0 and C0).
3.5. Nrp1 recycles in a Rab11-dependent manner
While it is known that Nrp1 undergoes clathrin and Rab5-
dependent endocytosis [31], the mechanisms that confer c be char-
acterized. We sought to identify which Rab GTPase colocalizes with
it. Nrp1 colocalized extensively with Rab11 (Fig. 5A–D), but not
with Rab4 (data not shown), suggesting that it underwent slow
recycling via perinuclear endosomes [32]. Indeed, by 30 min the
majority of the cytoplasmic Nrp1 population was localized to the
perinuclear region (Fig. 5D). In nrp1cytoD/D ECs, Nrp1 did not colo-
Fig. 3. Confocal immunoﬂuorescence images showing that the colocalization of Nrp1 and FlnA depends on the presence of the Nrp1 cytoplasmic domain and on VEGF. Mouse
nrp1+/+ (A–D) or nrp1cytoD/D (A0 and C0) heart ECs immunolabeled against FlnA (red) and Nrp1 (green) are seen at the indicated time points after the application of VEGF-A164
(20 ng/ml). The magniﬁed subﬁelds correspond to the area in the white squares. Arrowheads denote colocalized punctae of FlnA and Nrp1. Scale bars, 10 lm.
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required for the recruitment of Nrp1 to Rab11-carrying vesicles
(Fig. 5A0 and C0).
3.6. VEGF-induced migration and rate of FA turnover are slower in
nrp1cytoD/D ECs
The association of Nrp1 with FA proteins both in vesicles and in
FAs of VEGF-treated ECs raised the possibility that Nrp1 may be in-
volved in FA turnover, and, consequently, in regulating VEGF-in-
duced cell migration. To test this premise, we compared the rates
of gap closure by nrp1+/+ and nrp1cytoD/D ECs in the presence of
VEGF-A. The rate of VEGF-induced gap closure by nrp1cytoD/D ECs
was signiﬁcantly lower than the gap closure rate by the same cell
type in the absence of VEGF (Fig. 6).
We chose kindlin-2 as a marker for tracking FAs in live cells,
because it associates with FlnA [33], like Nrp1. To test directly
the rate of FA turnover in nrp1+/+ and nrp1cytoD/D ECs, we transfec-
ted each cell type by kindlin-2 fused to the ﬂuorescent protein
mCherry (mCherry-K2). We then imaged the dynamics of the
mCherry-K2 in basal FAs using total internal reﬂection ﬂuores-
cence (TIRF). By tracking the rate of the appearance or removal
of kindlin-2 from individual FAs, we measured the rate constants
of FA assembly and disassembly, respectively, in wild type and innrp1cytoD/D ECs, after the administration of VEGF-A164. We found
that the rates of both the assembly and disassembly of FAs were
approximately an order of a magnitude lower in the nrp1cytoD/D
ECs (Fig. 7, Supplemental videos 1, 2), thus suggesting that the
cytoplasmic domain of Nrp1 is required for the turnover of FAs
in VEGF-treated ECs.
4. Discussion
The precise contribution of Nrp1 to VEGF signaling and in par-
ticular, the role of the Nrp1 cytoplasmic domain have been debated
since the discovery that Nrp1 is a VEGF co-receptor [34]. Recent re-
port suggests that the Nrp1 cytoplasmic tail is dispensable for
developmental and pathological angiogenesis [35], but essential
for VEGF-induced arteriogenesis in both physiological and ische-
mic settings [11]. As recently discussed [36], by default, the puta-
tive contribution of Nrp1 to VEGF signaling would involve the
cytoplasmic domain of Nrp1. Since the cytoplasmic domain is only
44 residues long and appears to be devoid of catalytic activity, the
most likely manner in which this domain acts in VEGF signaling is
by the binding and assembly of other proteins, such as synectin
[11], or FlnA.
The picture that emerges from this study is that Nrp1 localizes
mainly along the trafﬁcking pathway of several FA components,
Fig. 4. Colocalization of Nrp1 and p130Cas is not VEGF dependent but requires the Nrp1 cytoplasmic domain. Confocal immunoﬂuorescence images of mouse nrp1+/+ (A–D) or
of nrp1cytoD/D (A0 and C0) heart ECs immunolabeled against p130Cas (red) and Nrp1 (green) at the indicated time points after the application of VEGF-A164 (20 ng/ml). Scale
bars, 10 lm. (E) Time course of the extent of colocalization between p130Cas and Nrp1. (F) p130Cas immunoblot of lysate samples of WT heart ECs immunoprecipitated by
anti-Nrp1 at the indicated time points.
Fig. 5. Rab11 and Nrp1 colocalize and trafﬁc together following VEGF stimulation in a Nrp1 cytoplasmic domain dependent manner. Confocal immunoﬂuorescence images of
mouse nrp1+/+ (A–D) or of nrp1cytoD/D (A0 and C0) heart ECs immunolabeled against Rab11 (red) and Nrp1 (green) at the indicated time points after the application of VEGF-A164
(20 ng/ml). Scale bars, 10 lm.
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Fig. 7. Deletion of the Nrp1 cytoplasmic domain slows down FA turnover. (A and A0) TIRF mages of FAs (encircled in red line) in nrp1+/+ and nrp1cytoD/D ECs, respectively. (B
and C, B0 and C0) Time course of the relative ﬂuorescence intensities of assembling (B and B0) or disassembling (C and C0) individual FAs. (D) The mean rates of assembly and
disassembly of nrp1+/+ (black columns) and nrp1cytoD/D (grey columns) ECs. The rates from four cells and 15 FAs were measured for each cell type (p = 1.3  107; 4.9  109)
Fig. 6. Cell migration is impeded by deletion of the Nrp1 cytoplasmic domain. (A) Images of gaps between monolayers of nrp1+/+ or of nrp1cytoD/D (KI) cells before and 6 h after
treatment with 50 ng/ml VEGF-A164. The edges of the monolayers are delineated by a black line. (B) Time course of gap closure of nrp1+/+ (triangles) and nrp1cytoD/D ECs
(squares) ECs (n = 3, p = 0.036, 0.009).
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Fig. 8. Schematic representation of the function of Nrp1 in focal adhesion turnover.
According to this scenario, Nrp1 is endocytosed in response to VEGF, targeted to
focal adhesions, where it resides transiently, and then departs with FlnA bound to
its cytoplasmic domain. The Nrp1–FlnA complex recycles back in a Rab11-
dependent manner. Speculatively, p130Cas remains associated with Nrp1 through-
out this process.
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sides in FAs only transiently. Since the distribution of Nrp1 in qui-
escent ECs is along the cell borders, it appears that the role of Nrp1
in FA dynamics triggered by the application of VEGF is in driving
their disassembly (Fig. 8). The membrane trafﬁc of Nrp1 appears
to be dependent on Rab11, in agreement with previous studies
[11,37]. Thus, it is likely that Nrp1 mediates FA turnover in re-
sponse to VEGF by recycling several FA components, including
FlnA. While these components can be thought of as cargo, Nrp1
probably provides the means to mobilize the vesicles to which they
are bound by cross-linking them to myosin VI via synectin. The
vastly slower FA turnover in the nrp1cytoD/D ECs in response to
VEGF, where the truncated Nrp1 mutant is unable to bind synectin,
is the likely cause of the reduced rate of migration of these cells.
This impaired migration could account at least in part for the vas-
cular defect observed in vivo in the nrp1cytoD/D mouse model [11].
Other studies proposed that Nrp1 is involved in VEGF-induced
tyrosine phosphorylation of FA kinase and, consequently, in the
regulation of FA assembly [38]. The possible involvement of Nrp1
in the regulation of FA turnover was deduced also from its role
in stimulating the phosphorylation of the scaffold protein
p130Cas, a known component of FAs [30]. Functional associations
between Nrp1 and FAs have been reported previously. Several
studies found links between Nrp1 and the FA protein p130Cas,
wherein Nrp1 promoted the migration of several cell types via
the tyrosine phosphorylation of p130Cas [19,28,29]. Here we ex-
pand those studies by observing the association between Nrp1
and p130Cas, and their widespread colocalization. Nrp2 was also
reported to be involved in the formation of FAs through the regu-
lation of the activity of integrin a6b1, and was shown to be abun-
dant in FAs [39].
Interestingly, FlnA had been reported to regulate the recycling
of the calcitonin receptor (CTR), a G-protein coupled receptor that
is involved in the maintenance of calcium homeostasis [40]. Simi-
lar to Nrp1, the C-terminus of CTR binds FlnA. While our study did
not test directly if FlnA regulates the recycling of Nrp1, it should be
pointed out that the recycling mechanisms and interaction with
FlnA differ between the two receptors. Whereas CTR undergoes to-
nic endocytosis and binds FlnA constitutively, Nrp1 undergoes
VEGF-triggered endocytosis and, given the immunoﬂuorescence
data, binds FlnA transiently. It is unlikely therefore that FlnA regu-
lates the recycling of Nrp1. In a separate study, FlnA was found to
regulate the rate of FA disassembly in a calpain-dependent manner
[18]. We observed that once cells were activated by VEGF, FlnA was
displaced from the cell borders, where it would have been in close
proximity to peripheral FAs. It is possible, therefore, that the VEGF/
Nrp1-dependent dynamics of FlnA contributes to FA disassembly.In conclusion, Nrp1 interacts with several focal adhesion proteins.
Since Nrp1 is also a VEGF coreceptor, it is in a position to act as an
interface between the VEGF signaling pathway and FA dynamics.
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